Yersiniosis can be accompanied by ocular involvement. When uveitis arises in this context, the inflammation inside the eye requires its own targeted management alongside treatment of the underlying infection.
Uveitis in the setting of Yersiniosis demands a structured ocular approach. Managing intraocular inflammation typically begins with mydriatics and steroids delivered as eye drops to address local disease.
When ocular lesions persist despite initial topical measures, escalation of therapy may be required — including consideration of a systemic oral glucocorticosteroid. The complete eligibility criteria, therapeutic sequence, and regimen details are reserved for the full structured protocol.
The treatment of uveitis requires the use of mydriatics and steroids in the form of eye drops.
In severe cases, if the lesions do not resolve, an oral GCS may be necessary.
View source ↗